| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 59.01 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Intestinal microbiota may influence inflammation in the host. The aim of the
present study was to explore the role of modulation of intestinal microbiota in the
outcome in the Helicobacter pylori (Hp) gastric inflammation.
Twenty five C57BL/6 male mice were separated in three groups: Control group
(CG) n = 5 Infected group (IG) n = 10 and Synbiotic 2000TM (SG) n = 10. CG
received PBS by gavage; IG and SG were inoculated intragastrically with H. pylori
SS1 cell suspension (109 CFU/mL). Then, mice were treated either with PBS (CG
and IG) or Synbiotic 2000TM (SG). Five mice from each group were sacrificed at
week 6 and the other at week 18. At each time samples were collected from:
gastric tissue to immunohistochemistry and histological evaluation (HE) and
faeces to evaluate intestinal microbiota composition by FISH, targeting 14
bacterial groups.
IG and SG groups were H. pylori positive by immunohistochemistry. Microbiota
analysis: In IG there were significant changes in the microbiota composition,
comparing to CG. At week 6 there were changes in 12 of 14 (85.7%) bacterial
groups, while at week 18 there was a change in 6/14 (42.9%). In SG, there were
changes in 7/14 (50.0%) at week 6, and in 4/14 (28.6%) at week 18, comparing
to CG. Histology: IG at weeks 6 and 18 has 40% (2/5) of intramucosal
inflammation and SG at the same end points has 0% (0/5).
These results suggest that modulation of the intestinal microbiota by Synbiotic
2000TM may influence the outcome of Hp gastric inflammation.
Description
Keywords
Helicobacter pylori Intestinal microbiota Infecções Gastrointestinais
Pedagogical Context
Citation
European Helicobacter Study Group: Abstracts of the XXIVth International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer. Helicobacter 16 (Suppl. 1): 140. Epub 2011 Sep 7
Publisher
Blackwell Publishing Lta
